Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,518,700 | 536,800 | 320,600 | 1,472,700 | 1,320,800 |
| Receivables | 2,097,000 | 2,098,700 | 1,997,300 | 2,978,300 | 3,016,600 |
| Inventories | 493,200 | 474,600 | 470,600 | 401,400 | 423,200 |
| Other current assets | 0 | 0 | 1,226,100 | 0 | 0 |
| TOTAL | $4,806,500 | $3,765,400 | $4,625,000 | $5,330,500 | $5,125,400 |
| Non-Current Assets | |||||
| PPE Net | 3,045,400 | 2,911,800 | 2,794,100 | 2,815,400 | 2,729,600 |
| Investments And Advances | 16,300 | 26,900 | 65,700 | 60,900 | 73,500 |
| Intangibles | 9,858,600 | 9,484,500 | 9,247,300 | 11,694,400 | 11,712,600 |
| Other Non-Current Assets | 652,200 | 536,500 | 3,423,000 | 484,200 | 430,600 |
| TOTAL | $13,572,500 | $12,959,700 | $15,530,100 | $15,054,900 | $14,946,300 |
| Total Assets | $18,379,000 | $16,725,100 | $20,155,100 | $20,385,400 | $20,071,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 875,800 | 827,500 | 852,200 | 621,300 | 638,900 |
| Accrued Expenses | 871,200 | 804,000 | 787,000 | 1,404,100 | 1,357,700 |
| TOTAL | $3,330,200 | $3,225,200 | $3,078,500 | $2,782,900 | $3,078,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,331,200 | 4,054,700 | 5,038,800 | 5,416,500 | 5,419,000 |
| Deferred Revenues | 392,200 | 421,700 | 310,600 | 558,500 | 506,500 |
| Other Non-Current Liabilities | 1,206,900 | 1,072,499 | 1,312,700 | 1,062,900 | 1,223,800 |
| TOTAL | $6,996,600 | $5,624,899 | $6,980,000 | $7,329,100 | $7,556,600 |
| Total Liabilities | $10,326,800 | $8,850,100 | $10,058,500 | $10,112,000 | $10,635,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,700 | 84,100 | 88,500 | 93,400 | 97,600 |
| Common Shares | 7,600 | 7,700 | 8,100 | 8,500 | 9,000 |
| Retained earnings | 8,303,400 | 7,888,200 | 10,581,700 | 10,456,800 | 9,479,200 |
| Other shareholders' equity | -261,600 | -59,300 | -493,200 | -191,900 | -161,900 |
| TOTAL | $8,052,200 | $7,875,000 | $10,096,600 | $10,273,400 | $9,436,600 |
| Total Liabilities And Equity | $18,379,000 | $16,725,100 | $20,155,100 | $20,385,400 | $20,071,700 |